Pnc Financial Services Group, Inc. Dare Bioscience, Inc. Transaction History

Pnc Financial Services Group, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$0.28 - $0.61 $392 - $854	-1,400 Reduced 31.82%	3,000 $1,000
Q3 2022 Nov 10, 2022	BUY	$1.04 - $12.48 $1,040 - $12,480	1,000 Added 29.41%	4,400 $0
Q2 2022 Aug 12, 2022	BUY	$0.94 - $1.76 $940 - $1,760	1,000 Added 41.67%	3,400 $4,000
Q4 2021 Feb 11, 2022	BUY	$1.42 - $2.13 $1,420 - $2,130	1,000 Added 71.43%	2,400 $4,000
Q3 2021 Nov 05, 2021	BUY	$1.42 - $2.0 $1,988 - $2,800	1,400 New	1,400 $2,000
Q2 2018 Aug 10, 2018	SELL	$0.76 - $1.48 $38 - $74	-50 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$0.83 - $2.79 $41 - $139	50 New	50 $0

267K

Ticker DARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,820,896
Market Cap $271M
Description
Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription pr...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.